BRIEF-Nanthealth announces exclusive agreement with Oncotest-Teva

* Under terms of agreement, Oncotest-Teva will have exclusive rights to distribute GPS cancer to physicians in Israel.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.